CONTEXT: In mice, scavenger receptor class B, type I (SR-BI) receptor protein deficiency is associated with elevated high-density lipoprotein (HDL)-cholesterol (HDL-C) levels. OBJECTIVE: Our objective was to determine the relationship between SR-BI protein and HDL-C levels in humans. DESIGN: This was a prospective study of adults with hyperalphalipoproteinemia. Fasting blood was obtained for lipid and lipoprotein measurement, genomic DNA, and monocyte-derived macrophages. SR-BI protein levels were measured by Western blots, and SR-BI activity was measured by cholesteryl ester (CE) uptake of each donor's radiolabeled HDL with their monocyte-derived macrophages, or by degradation and specific cell association of dual-labeled HDL in vitro. SETTING: The study was performed in a tertiary university teaching hospital. RESULTS: The mean age was 57.2 +/- 10.9 yr (n = 65). SR-BI protein levels were inversely associated with HDL-C levels (P < 0.002), HDL particle size (P < 0.05), and positively associated with CE uptake (P < 0.004); there was no association with plasma apolipoprotein levels. SR-BI protein levels (P = 0.01) were independent predictors of HDL-C levels. Subjects who were carriers of the A allele for the rs4238001 (glycine to serine at position 2) polymorphism [single nucleotide polymorphism (SNP)] had lower SR-BI protein levels (P = 0.01), whereas carriers of the C allele for the rs2278986 SNP also had lower SR-BI protein levels (P = 0.02). Body mass index (P = 0.05), rs4238001 (P = 0.01), and rs2278986 (P = 0.01) SNPs were independent predictors of SR-BI protein levels. In vitro studies of murine macrophages stably expressing the glycine to serine at position 2 SNP showed less degradation (P < 0.0004) and specific cell association (P < 0.0004) of [(125)I, (3)H]-CE-labeled HDL. CONCLUSIONS: SR-BI protein has an independent effect on HDL-C levels in women with hyperalphalipoproteinemia. Two SNPs were significantly associated with lower SR-BI protein levels.
CONTEXT: In mice, scavenger receptor class B, type I (SR-BI) receptor protein deficiency is associated with elevated high-density lipoprotein (HDL)-cholesterol (HDL-C) levels. OBJECTIVE: Our objective was to determine the relationship between SR-BI protein and HDL-C levels in humans. DESIGN: This was a prospective study of adults with hyperalphalipoproteinemia. Fasting blood was obtained for lipid and lipoprotein measurement, genomic DNA, and monocyte-derived macrophages. SR-BI protein levels were measured by Western blots, and SR-BI activity was measured by cholesteryl ester (CE) uptake of each donor's radiolabeled HDL with their monocyte-derived macrophages, or by degradation and specific cell association of dual-labeled HDL in vitro. SETTING: The study was performed in a tertiary university teaching hospital. RESULTS: The mean age was 57.2 +/- 10.9 yr (n = 65). SR-BI protein levels were inversely associated with HDL-C levels (P < 0.002), HDL particle size (P < 0.05), and positively associated with CE uptake (P < 0.004); there was no association with plasma apolipoprotein levels. SR-BI protein levels (P = 0.01) were independent predictors of HDL-C levels. Subjects who were carriers of the A allele for the rs4238001 (glycine to serine at position 2) polymorphism [single nucleotide polymorphism (SNP)] had lower SR-BI protein levels (P = 0.01), whereas carriers of the C allele for the rs2278986 SNP also had lower SR-BI protein levels (P = 0.02). Body mass index (P = 0.05), rs4238001 (P = 0.01), and rs2278986 (P = 0.01) SNPs were independent predictors of SR-BI protein levels. In vitro studies of murine macrophages stably expressing the glycine to serine at position 2 SNP showed less degradation (P < 0.0004) and specific cell association (P < 0.0004) of [(125)I, (3)H]-CE-labeled HDL. CONCLUSIONS:SR-BI protein has an independent effect on HDL-C levels in women with hyperalphalipoproteinemia. Two SNPs were significantly associated with lower SR-BI protein levels.
Authors: B Jian; M de la Llera-Moya; Y Ji; N Wang; M C Phillips; J B Swaney; A R Tall; G H Rothblat Journal: J Biol Chem Date: 1998-03-06 Impact factor: 5.157
Authors: S Acton; D Osgood; M Donoghue; D Corella; M Pocovi; A Cenarro; P Mozas; J Keilty; S Squazzo; E A Woolf; J M Ordovas Journal: Arterioscler Thromb Vasc Biol Date: 1999-07 Impact factor: 8.311
Authors: K Hirano; S Yamashita; Y Nakagawa; T Ohya; F Matsuura; K Tsukamoto; Y Okamoto; A Matsuyama; K Matsumoto; J Miyagawa; Y Matsuzawa Journal: Circ Res Date: 1999-07-09 Impact factor: 17.367
Authors: Y Ji; B Jian; N Wang; Y Sun; M L Moya; M C Phillips; G H Rothblat; J B Swaney; A R Tall Journal: J Biol Chem Date: 1997-08-22 Impact factor: 5.157
Authors: Maria Pia Adorni; Francesca Zimetti; Jeffrey T Billheimer; Nan Wang; Daniel J Rader; Michael C Phillips; George H Rothblat Journal: J Lipid Res Date: 2007-08-29 Impact factor: 5.922
Authors: Vipavee Niemsiri; Xingbin Wang; Dilek Pirim; Zaheda H Radwan; John E Hokanson; Richard F Hamman; M Michael Barmada; F Yesim Demirci; M Ilyas Kamboh Journal: Circ Cardiovasc Genet Date: 2014-09-22
Authors: Ricquita D Pollard; Christopher N Blesso; Manal Zabalawi; Brian Fulp; Mark Gerelus; Xuewei Zhu; Erica W Lyons; Nebil Nuradin; Omar L Francone; Xiang-An Li; Daisy Sahoo; Michael J Thomas; Mary G Sorci-Thomas Journal: J Biol Chem Date: 2015-05-06 Impact factor: 5.157
Authors: Diana Golden; Antonina Kolmakova; Sunitha Sura; Anthony T Vella; Ani Manichaikul; Xin-Qun Wang; Suzette J Bielinski; Kent D Taylor; Yii-Der Ida Chen; Stephen S Rich; Annabelle Rodriguez Journal: JCI Insight Date: 2016-10-20
Authors: Mingming Gao; Dong Zhao; Sarah Schouteden; Mary G Sorci-Thomas; Paul P Van Veldhoven; Kristel Eggermont; George Liu; Catherine M Verfaillie; Yingmei Feng Journal: Arterioscler Thromb Vasc Biol Date: 2014-06-26 Impact factor: 8.311